MARKET INTRODUCTION
Vaccines, also known as immunizations, inject a weakened form of a disease into a person so the body begins producing antibodies or immunity against the disease. Effective immunization has eradicated a number of diseases, like polio and smallpox, with high death rates. Vaccinations play a crucial role to maintain sustainable health of people across different countries.
MARKET DYNAMICS
The vaccines & vaccination market growth is driven by factors such high prevalence of infectious diseases, increasing company initiatives to enhance vaccine R&D, growing government support for vaccine development, and the rising focus on immunization. However, the huge capital investments required for developing vaccines may restrain market growth.
MARKET SCOPE
The "Vaccines & Vaccination Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of vaccines & vaccination market with detailed market segmentation technology, indication, end user and region. The vaccines & vaccination market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in vaccines & vaccination market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The vaccines & vaccination market is segmented on the basis of technology, indication, end user. Depending on technology, the market is classified into recombinant & conjugate vaccines, live attenuated vaccines, inactivated vaccines, toxoid vaccines, and others. By indication, the market is classified into pneumococcal disease, influenza, human papilloma virus, meningococcal disease, rotavirus, varicella; diphtheria, pertussis, & tetanus (DPT), polio, hepatitis; measles, mumps, & rubella (MMR), and other indications. According to end user, the market is segmented into pediatric, adults, and travelers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Vaccines & Vaccination market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Vaccines & Vaccination market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Vaccines & Vaccination market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Vaccines & Vaccination market in these regions.
MARKET PLAYERS
The report covers key developments in the vaccines & vaccination market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from vaccines & vaccination market are anticipated to have lucrative growth opportunities in the future with the rising demand for vaccines & vaccination market in the global market. Below mentioned is the list of few companies engaged in the vaccines & vaccination market.
The report also includes the profiles of key players in vaccines & vaccination market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Serum Institute of India Pvt. Ltd.
Pfizer
Johnson & Johnson
AstraZenecea plc
GlaxoSmithKline plc
Sanofi Aventis
Merck & Co., Inc.
Emergent BioSolutions Inc.
CSL Limited
Novavax, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vaccines And Vaccination Market - By Technology
1.3.2 Vaccines And Vaccination Market - By Indication
1.3.3 Vaccines And Vaccination Market - By End User
1.3.4 Vaccines And Vaccination Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VACCINES AND VACCINATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VACCINES AND VACCINATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VACCINES AND VACCINATION MARKET - GLOBAL MARKET ANALYSIS
6.1. VACCINES AND VACCINATION - GLOBAL MARKET OVERVIEW
6.2. VACCINES AND VACCINATION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. VACCINES AND VACCINATION MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. RECOMBINANT AND CONJUGATE VACCINES
7.3.1. Overview
7.3.2. Recombinant and Conjugate Vaccines Market Forecast and Analysis
7.4. LIVE ATTENUATED VACCINES
7.4.1. Overview
7.4.2. Live Attenuated Vaccines Market Forecast and Analysis
7.5. INACTIVATED VACCINES
7.5.1. Overview
7.5.2. Inactivated Vaccines Market Forecast and Analysis
7.6. TOXOID VACCINES
7.6.1. Overview
7.6.2. Toxoid Vaccines Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. VACCINES AND VACCINATION MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. PNEUMOCOCCAL DISEASE
8.3.1. Overview
8.3.2. Pneumococcal Disease Market Forecast and Analysis
8.4. INFLUENZA
8.4.1. Overview
8.4.2. Influenza Market Forecast and Analysis
8.5. HUMAN PAPILLOMA VIRUS
8.5.1. Overview
8.5.2. Human Papilloma Virus Market Forecast and Analysis
8.6. MENINGOCOCCAL DISEASE
8.6.1. Overview
8.6.2. Meningococcal Disease Market Forecast and Analysis
8.7. ROTAVIRUS
8.7.1. Overview
8.7.2. Rotavirus Market Forecast and Analysis
8.8. VARICELLA
8.8.1. Overview
8.8.2. Varicella Market Forecast and Analysis
8.9. DIPHTHERIA
8.9.1. Overview
8.9.2. Diphtheria Market Forecast and Analysis
8.10. POLIO
8.10.1. Overview
8.10.2. Polio Market Forecast and Analysis
8.11. HEPATITIS
8.11.1. Overview
8.11.2. Hepatitis Market Forecast and Analysis
8.12. OTHER INDICATIONS
8.12.1. Overview
8.12.2. Other Indications Market Forecast and Analysis
9. VACCINES AND VACCINATION MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PEDIATRIC
9.3.1. Overview
9.3.2. Pediatric Market Forecast and Analysis
9.4. ADULTS
9.4.1. Overview
9.4.2. Adults Market Forecast and Analysis
9.5. TRAVELERS
9.5.1. Overview
9.5.2. Travelers Market Forecast and Analysis
10. VACCINES AND VACCINATION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Vaccines And Vaccination Market Overview
10.1.2 North America Vaccines And Vaccination Market Forecasts and Analysis
10.1.3 North America Vaccines And Vaccination Market Forecasts and Analysis - By Technology
10.1.4 North America Vaccines And Vaccination Market Forecasts and Analysis - By Indication
10.1.5 North America Vaccines And Vaccination Market Forecasts and Analysis - By End User
10.1.6 North America Vaccines And Vaccination Market Forecasts and Analysis - By Countries
10.1.6.1 United States Vaccines And Vaccination Market
10.1.6.1.1 United States Vaccines And Vaccination Market by Technology
10.1.6.1.2 United States Vaccines And Vaccination Market by Indication
10.1.6.1.3 United States Vaccines And Vaccination Market by End User
10.1.6.2 Canada Vaccines And Vaccination Market
10.1.6.2.1 Canada Vaccines And Vaccination Market by Technology
10.1.6.2.2 Canada Vaccines And Vaccination Market by Indication
10.1.6.2.3 Canada Vaccines And Vaccination Market by End User
10.1.6.3 Mexico Vaccines And Vaccination Market
10.1.6.3.1 Mexico Vaccines And Vaccination Market by Technology
10.1.6.3.2 Mexico Vaccines And Vaccination Market by Indication
10.1.6.3.3 Mexico Vaccines And Vaccination Market by End User
10.2. EUROPE
10.2.1 Europe Vaccines And Vaccination Market Overview
10.2.2 Europe Vaccines And Vaccination Market Forecasts and Analysis
10.2.3 Europe Vaccines And Vaccination Market Forecasts and Analysis - By Technology
10.2.4 Europe Vaccines And Vaccination Market Forecasts and Analysis - By Indication
10.2.5 Europe Vaccines And Vaccination Market Forecasts and Analysis - By End User
10.2.6 Europe Vaccines And Vaccination Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Vaccines And Vaccination Market
10.2.6.1.1 Germany Vaccines And Vaccination Market by Technology
10.2.6.1.2 Germany Vaccines And Vaccination Market by Indication
10.2.6.1.3 Germany Vaccines And Vaccination Market by End User
10.2.6.2 France Vaccines And Vaccination Market
10.2.6.2.1 France Vaccines And Vaccination Market by Technology
10.2.6.2.2 France Vaccines And Vaccination Market by Indication
10.2.6.2.3 France Vaccines And Vaccination Market by End User
10.2.6.3 Italy Vaccines And Vaccination Market
10.2.6.3.1 Italy Vaccines And Vaccination Market by Technology
10.2.6.3.2 Italy Vaccines And Vaccination Market by Indication
10.2.6.3.3 Italy Vaccines And Vaccination Market by End User
10.2.6.4 Spain Vaccines And Vaccination Market
10.2.6.4.1 Spain Vaccines And Vaccination Market by Technology
10.2.6.4.2 Spain Vaccines And Vaccination Market by Indication
10.2.6.4.3 Spain Vaccines And Vaccination Market by End User
10.2.6.5 United Kingdom Vaccines And Vaccination Market
10.2.6.5.1 United Kingdom Vaccines And Vaccination Market by Technology
10.2.6.5.2 United Kingdom Vaccines And Vaccination Market by Indication
10.2.6.5.3 United Kingdom Vaccines And Vaccination Market by End User
10.2.6.6 Rest of Europe Vaccines And Vaccination Market
10.2.6.6.1 Rest of Europe Vaccines And Vaccination Market by Technology
10.2.6.6.2 Rest of Europe Vaccines And Vaccination Market by Indication
10.2.6.6.3 Rest of Europe Vaccines And Vaccination Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Vaccines And Vaccination Market Overview
10.3.2 Asia-Pacific Vaccines And Vaccination Market Forecasts and Analysis
10.3.3 Asia-Pacific Vaccines And Vaccination Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Vaccines And Vaccination Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Vaccines And Vaccination Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Vaccines And Vaccination Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Vaccines And Vaccination Market
10.3.6.1.1 Australia Vaccines And Vaccination Market by Technology
10.3.6.1.2 Australia Vaccines And Vaccination Market by Indication
10.3.6.1.3 Australia Vaccines And Vaccination Market by End User
10.3.6.2 China Vaccines And Vaccination Market
10.3.6.2.1 China Vaccines And Vaccination Market by Technology
10.3.6.2.2 China Vaccines And Vaccination Market by Indication
10.3.6.2.3 China Vaccines And Vaccination Market by End User
10.3.6.3 India Vaccines And Vaccination Market
10.3.6.3.1 India Vaccines And Vaccination Market by Technology
10.3.6.3.2 India Vaccines And Vaccination Market by Indication
10.3.6.3.3 India Vaccines And Vaccination Market by End User
10.3.6.4 Japan Vaccines And Vaccination Market
10.3.6.4.1 Japan Vaccines And Vaccination Market by Technology
10.3.6.4.2 Japan Vaccines And Vaccination Market by Indication
10.3.6.4.3 Japan Vaccines And Vaccination Market by End User
10.3.6.5 South Korea Vaccines And Vaccination Market
10.3.6.5.1 South Korea Vaccines And Vaccination Market by Technology
10.3.6.5.2 South Korea Vaccines And Vaccination Market by Indication
10.3.6.5.3 South Korea Vaccines And Vaccination Market by End User
10.3.6.6 Rest of Asia-Pacific Vaccines And Vaccination Market
10.3.6.6.1 Rest of Asia-Pacific Vaccines And Vaccination Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Vaccines And Vaccination Market by Indication
10.3.6.6.3 Rest of Asia-Pacific Vaccines And Vaccination Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Vaccines And Vaccination Market Overview
10.4.2 Middle East and Africa Vaccines And Vaccination Market Forecasts and Analysis
10.4.3 Middle East and Africa Vaccines And Vaccination Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Vaccines And Vaccination Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Vaccines And Vaccination Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Vaccines And Vaccination Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Vaccines And Vaccination Market
10.4.6.1.1 South Africa Vaccines And Vaccination Market by Technology
10.4.6.1.2 South Africa Vaccines And Vaccination Market by Indication
10.4.6.1.3 South Africa Vaccines And Vaccination Market by End User
10.4.6.2 Saudi Arabia Vaccines And Vaccination Market
10.4.6.2.1 Saudi Arabia Vaccines And Vaccination Market by Technology
10.4.6.2.2 Saudi Arabia Vaccines And Vaccination Market by Indication
10.4.6.2.3 Saudi Arabia Vaccines And Vaccination Market by End User
10.4.6.3 U.A.E Vaccines And Vaccination Market
10.4.6.3.1 U.A.E Vaccines And Vaccination Market by Technology
10.4.6.3.2 U.A.E Vaccines And Vaccination Market by Indication
10.4.6.3.3 U.A.E Vaccines And Vaccination Market by End User
10.4.6.4 Rest of Middle East and Africa Vaccines And Vaccination Market
10.4.6.4.1 Rest of Middle East and Africa Vaccines And Vaccination Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Vaccines And Vaccination Market by Indication
10.4.6.4.3 Rest of Middle East and Africa Vaccines And Vaccination Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Vaccines And Vaccination Market Overview
10.5.2 South and Central America Vaccines And Vaccination Market Forecasts and Analysis
10.5.3 South and Central America Vaccines And Vaccination Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Vaccines And Vaccination Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Vaccines And Vaccination Market Forecasts and Analysis - By End User
10.5.6 South and Central America Vaccines And Vaccination Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Vaccines And Vaccination Market
10.5.6.1.1 Brazil Vaccines And Vaccination Market by Technology
10.5.6.1.2 Brazil Vaccines And Vaccination Market by Indication
10.5.6.1.3 Brazil Vaccines And Vaccination Market by End User
10.5.6.2 Argentina Vaccines And Vaccination Market
10.5.6.2.1 Argentina Vaccines And Vaccination Market by Technology
10.5.6.2.2 Argentina Vaccines And Vaccination Market by Indication
10.5.6.2.3 Argentina Vaccines And Vaccination Market by End User
10.5.6.3 Rest of South and Central America Vaccines And Vaccination Market
10.5.6.3.1 Rest of South and Central America Vaccines And Vaccination Market by Technology
10.5.6.3.2 Rest of South and Central America Vaccines And Vaccination Market by Indication
10.5.6.3.3 Rest of South and Central America Vaccines And Vaccination Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL VACCINES AND VACCINATION MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. VACCINES AND VACCINATION MARKET, KEY COMPANY PROFILES
13.1. SERUM INSTITUTE OF INDIA PVT. LTD.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PFIZER
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. JOHNSON AND JOHNSON
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ASTRAZENECEA PLC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GLAXOSMITHKLINE PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SANOFI AVENTIS
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MERCK AND CO., INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. EMERGENT BIOSOLUTIONS INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. CSL LIMITED
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. NOVAVAX, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Serum Institute of India Pvt. Ltd.
2. Pfizer
3. Johnson & Johnson
4. AstraZenecea plc
5. GlaxoSmithKline plc
6. Sanofi Aventis
7. Merck & Co., Inc.
8. Emergent BioSolutions Inc.
9. CSL Limited
10. Novavax, Inc.